NOP56
Basic information
Region (hg38): 20:2652593-2658393
Previous symbols: [ "NOL5A" ]
Links
Phenotypes
GenCC
Source:
- spinocerebellar ataxia type 36 (Definitive), mode of inheritance: AD
- spinocerebellar ataxia type 36 (Supportive), mode of inheritance: AD
- spinocerebellar ataxia type 36 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spinocerebellar ataxia 36 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 21683323; 22744658; 22492559 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NOP56 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 40 | 45 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 40 | 7 | 7 |
Variants in NOP56
This is a list of pathogenic ClinVar variants found in the NOP56 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-2652657-C-T | Likely benign (Nov 01, 2024) | |||
20-2652843-T-G | Inborn genetic diseases | Uncertain significance (Dec 11, 2024) | ||
20-2652917-C-G | Inborn genetic diseases | Uncertain significance (Mar 08, 2025) | ||
20-2653290-T-C | not specified | Benign (-) | ||
20-2653342-C-T | Inborn genetic diseases | Uncertain significance (Jan 21, 2025) | ||
20-2653358-A-C | Inborn genetic diseases | Uncertain significance (Jan 22, 2025) | ||
20-2653360-G-C | Inborn genetic diseases | Uncertain significance (Oct 05, 2023) | ||
20-2654416-G-A | Inborn genetic diseases | Uncertain significance (Feb 26, 2025) | ||
20-2654477-T-C | Inborn genetic diseases | Uncertain significance (Oct 09, 2024) | ||
20-2654511-C-T | NOP56-related disorder | Likely benign (Oct 28, 2019) | ||
20-2654537-A-T | Inborn genetic diseases | Uncertain significance (Jan 26, 2025) | ||
20-2654566-A-G | not specified | Benign (-) | ||
20-2654739-CTCT-C | NOP56-related disorder | Benign (May 01, 2024) | ||
20-2654754-C-T | Inborn genetic diseases | Uncertain significance (May 31, 2023) | ||
20-2654755-G-A | Inborn genetic diseases | Uncertain significance (Feb 27, 2024) | ||
20-2654781-G-A | Inborn genetic diseases | Uncertain significance (Dec 16, 2024) | ||
20-2654830-G-C | Mild global developmental delay;Cerebellar ataxia | Uncertain significance (Jan 01, 2017) | ||
20-2654858-T-C | NOP56-related disorder | Benign (Apr 08, 2019) | ||
20-2654919-G-A | Inborn genetic diseases | Uncertain significance (Jul 21, 2021) | ||
20-2654941-G-A | Inborn genetic diseases | Uncertain significance (Jan 23, 2023) | ||
20-2655320-T-C | not specified | Likely benign (May 27, 2025) | ||
20-2655361-G-T | Inborn genetic diseases | Uncertain significance (Nov 07, 2023) | ||
20-2655369-A-G | Benign (Aug 01, 2024) | |||
20-2655370-C-T | Likely benign (Oct 01, 2024) | |||
20-2655390-G-A | Inborn genetic diseases | Uncertain significance (Aug 10, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NOP56 | protein_coding | protein_coding | ENST00000329276 | 12 | 6249 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.621 | 0.379 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.605 | 299 | 330 | 0.906 | 0.0000192 | 3875 |
Missense in Polyphen | 59 | 94.528 | 0.62416 | 1075 | ||
Synonymous | -0.995 | 142 | 128 | 1.11 | 0.00000716 | 1158 |
Loss of Function | 3.99 | 6 | 29.3 | 0.205 | 0.00000197 | 323 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000125 | 0.000121 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000123 | 0.000123 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the early to middle stages of 60S ribosomal subunit biogenesis. Core component of box C/D small nucleolar ribonucleoprotein (snoRNP) particles. Required for the biogenesis of box C/D snoRNAs such U3, U8 and U14 snoRNAs. {ECO:0000269|PubMed:12777385, ECO:0000269|PubMed:15574333}.;
- Disease
- DISEASE: Spinocerebellar ataxia 36 (SCA36) [MIM:614153]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA36 is characterized by complicated clinical features, with ataxia as the first symptom, followed by characteristic late-onset involvement of the motor neuron system. Ataxic symptoms, such as gait and truncal instability, ataxic dysarthria, and uncoordinated limbs, start in late forties to fifties. Characteristically, affected individuals exhibit tongue atrophy with fasciculation. Progression of motor neuron involvement is typically limited to the tongue and main proximal skeletal muscles in both upper and lower extremities. {ECO:0000269|PubMed:21683323}. Note=The disease is caused by mutations affecting the gene represented in this entry. Caused by large hexanucleotide CGCCTG repeat expansions within intron 1. These expansions induce RNA foci and sequester the RNA-binding protein SRSF2. In addition, the transcription of MIR1292, a microRNA gene located just 19 bp 3' of the GGCCTG repeat, is significantly decreased.;
- Pathway
- Ribosome biogenesis in eukaryotes - Homo sapiens (human);rRNA processing;Metabolism of proteins;Metabolism of RNA;Chaperonin-mediated protein folding;Association of TriC/CCT with target proteins during biosynthesis;Protein folding;rRNA modification in the nucleus and cytosol;rRNA processing in the nucleus and cytosol
(Consensus)
Recessive Scores
- pRec
- 0.377
Intolerance Scores
- loftool
- 0.285
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.53
Haploinsufficiency Scores
- pHI
- 0.990
- hipred
- Y
- hipred_score
- 0.831
- ghis
- 0.625
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.785
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nop56
- Phenotype
Zebrafish Information Network
- Gene name
- nop56
- Affected structure
- anatomical system
- Phenotype tag
- abnormal
- Phenotype quality
- quality
Gene ontology
- Biological process
- rRNA processing
- Cellular component
- fibrillar center;nucleoplasm;nucleolus;small nucleolar ribonucleoprotein complex;cytoplasm;membrane;box C/D snoRNP complex;small-subunit processome;pre-snoRNP complex
- Molecular function
- RNA binding;protein binding;snoRNA binding;cadherin binding;histone methyltransferase binding